Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 7—July 2022
Synopsis

Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men’s Correctional Facility, United States

Rachel A. Silverman1, Alessandro Ceci1, Alasdair Cohen, Meagan Helmick, Erica Short, Paige Bordwine, Michael J. Friedlander, and Carla V. FinkielsteinComments to Author 
Author affiliations: Virginia Tech, Blacksburg, Virginia, USA (R.A. Silverman, A. Cohen, M.J. Friedlander, C.V. Finkielstein); Fralin Biomedical Research Institute, Roanoke, Virginia, USA (A. Ceci, M.J. Friedlander, C.V. Finkielstein); Virginia Department of Health, Richmond, Virginia, USA (M. Helmick, E. Short, P. Bordwine).

Main Article

Table

Relative risk of SARS-CoV-2 infection among incarcerated persons during an outbreak at a men’s correctional facility in rural Virginia, April 2021*

Characteristic Unadjusted
Adjusted
No. persons RR (95% CI) No. persons RR (95% CI)
Combined
Unvaccinated vs. fully vaccinated 791 7.77 (4.75–12.69)† 787 8.82 (5.23–14.90)†
Age, 1 y increase 791 0.99 (0.98–1.01) 787 1.03 (1.01–1.05)‡
Race. Black vs. White
787
1.96 (1.19–3.258)‡

787
1.51 (0.91–2.49)
Stratified by vaccine status
Fully vaccinated
Age, 1 y increase 557 1.01 (0.97–1.05) 554 1.01 (0.97–1.05)
Race, Black vs. White 554 1.21 (0.48–3.02) 554 1.24 (0.49–3.14)
Unvaccinated
Age, 1 y increase 234 1.03 (1.01–1.05)‡ 233 1.04 (1.01–1.06)‡
Race, Black vs. White 233 1.40 (0.79–2.49) 233 1.70 (0.92–3.14)

*Relative risk calculated using Poisson regression. RR, relative risk. †p<0.001. ‡p<0.01.

Main Article

1These authors contributed equally to this article.

Page created: May 21, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external